1520 related articles for article (PubMed ID: 11114250)
1. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
2. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
Vogelsgesang M; Aktories K
Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
[TBL] [Abstract][Full Text] [Related]
3. Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex.
Han S; Craig JA; Putnam CD; Carozzi NB; Tainer JA
Nat Struct Biol; 1999 Oct; 6(10):932-6. PubMed ID: 10504727
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the Clostridium limosum C3 exoenzyme.
Vogelsgesang M; Stieglitz B; Herrmann C; Pautsch A; Aktories K
FEBS Lett; 2008 Apr; 582(7):1032-6. PubMed ID: 18325337
[TBL] [Abstract][Full Text] [Related]
5. Rho-specific Bacillus cereus ADP-ribosyltransferase C3cer cloning and characterization.
Wilde C; Vogelsgesang M; Aktories K
Biochemistry; 2003 Aug; 42(32):9694-702. PubMed ID: 12911311
[TBL] [Abstract][Full Text] [Related]
6. The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases.
Han S; Tainer JA
Int J Med Microbiol; 2002 Feb; 291(6-7):523-9. PubMed ID: 11890553
[TBL] [Abstract][Full Text] [Related]
7. C3 exoenzyme from Clostridium botulinum: structure of a tetragonal crystal form and a reassessment of NAD-induced flexure.
Evans HR; Holloway DE; Sutton JM; Ayriss J; Shone CC; Acharya KR
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1502-5. PubMed ID: 15272191
[TBL] [Abstract][Full Text] [Related]
8. Conformational plasticity is crucial for C3-RhoA complex formation by ARTT-loop.
Tsuge H; Yoshida T; Tsurumura T
Pathog Dis; 2015 Dec; 73(9):ftv094. PubMed ID: 26474844
[TBL] [Abstract][Full Text] [Related]
9. A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins.
Holbourn KP; Shone CC; Acharya KR
FEBS J; 2006 Oct; 273(20):4579-93. PubMed ID: 16956368
[TBL] [Abstract][Full Text] [Related]
10. NAD binding induces conformational changes in Rho ADP-ribosylating clostridium botulinum C3 exoenzyme.
Ménétrey J; Flatau G; Stura EA; Charbonnier JB; Gas F; Teulon JM; Le Du MH; Boquet P; Menez A
J Biol Chem; 2002 Aug; 277(34):30950-7. PubMed ID: 12029083
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition of an ADP-ribosylating Clostridium botulinum C3 exoenzyme by RalA GTPase.
Holbourn KP; Sutton JM; Evans HR; Shone CC; Acharya KR
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5357-62. PubMed ID: 15809419
[TBL] [Abstract][Full Text] [Related]
12. The uptake machinery of clostridial actin ADP-ribosylating toxins--a cell delivery system for fusion proteins and polypeptide drugs.
Barth H; Blöcker D; Aktories K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):501-12. PubMed ID: 12444490
[TBL] [Abstract][Full Text] [Related]
13. Rho-ADP-ribosylating exoenzyme from Bacillus cereus. Purification, characterization, and identification of the NAD-binding site.
Just I; Selzer J; Jung M; van Damme J; Vandekerckhove J; Aktories K
Biochemistry; 1995 Jan; 34(1):334-40. PubMed ID: 7819216
[TBL] [Abstract][Full Text] [Related]
14. Conserved structural motif for recognizing nicotinamide adenine dinucleotide in poly(ADP-ribose) polymerases and ADP-ribosylating toxins: implications for structure-based drug design.
Lee YM; Babu CS; Chen YC; Milcic M; Qu Y; Lim C
J Med Chem; 2010 May; 53(10):4038-49. PubMed ID: 20420408
[TBL] [Abstract][Full Text] [Related]
15. ADP-ribosylation of the rho/rac gene products by botulinum ADP-ribosyltransferase: identity of the enzyme and effects on protein and cell functions.
Narumiya S; Morii N; Sekine A; Kozaki S
J Physiol (Paris); 1990; 84(4):267-72. PubMed ID: 2127805
[TBL] [Abstract][Full Text] [Related]
16. Homology modeling and molecular dynamics studies of a novel C3-like ADP-ribosyltransferase.
Xiao JF; Li ZS; Sun CC
Bioorg Med Chem; 2004 May; 12(9):2035-41. PubMed ID: 15080907
[TBL] [Abstract][Full Text] [Related]
17. Salmonella enterica SpvB ADP-ribosylates actin at position arginine-177-characterization of the catalytic domain within the SpvB protein and a comparison to binary clostridial actin-ADP-ribosylating toxins.
Hochmann H; Pust S; von Figura G; Aktories K; Barth H
Biochemistry; 2006 Jan; 45(4):1271-7. PubMed ID: 16430223
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of the Rho-ADP-ribosylating exoenzyme C3stau2 from Staphylococcus aureus.
Wilde C; Just I; Aktories K
Biochemistry; 2002 Feb; 41(5):1539-44. PubMed ID: 11814347
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the C3bot-RalA complex reveals a novel type of action of a bacterial exoenzyme.
Pautsch A; Vogelsgesang M; Tränkle J; Herrmann C; Aktories K
EMBO J; 2005 Oct; 24(20):3670-80. PubMed ID: 16177825
[TBL] [Abstract][Full Text] [Related]
20. Substrate binding and catalysis of ecto-ADP-ribosyltransferase 2.2 from rat.
Ritter H; Koch-Nolte F; Marquez VE; Schulz GE
Biochemistry; 2003 Sep; 42(34):10155-62. PubMed ID: 12939142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
